乙型肝炎病毒介导的m6A脱甲基化增加肝细胞癌干细胞和免疫逃生
Yuting Meng1, Zheyue Shu2, Xueyao Wang3
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
Molecular cancer research : MCR
|March 28, 2024
概括
乙型肝炎病毒 (HBV) 感染通过稳定ALKBH5mRNA降低了肝癌中的N6-甲基氨酸 (m6A) 水平. 这通过ALKBH5/SNAI2通路促进癌症干和免疫逃避.
科学领域:
- 肝细胞癌研究 肝细胞癌研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 病毒瘤学 病毒瘤学
背景情况:
- 持续性乙型肝炎病毒 (HBV) 感染是肝细胞癌 (HCC) 的关键驱动因素.
- N6-甲基氨酸 (m6A) 修饰与各种癌症有关,但它们在与HBV相关的HCC干系中的作用尚不清楚.
研究的目的:
- 阐明m6A修饰在HBV阳性HCC中维持干性的调节机制.
- 调查ALKBH5及其下游标在HBV相关肝癌进展中的作用.
主要方法:
- 在HBV阳性HCC中分析m6A修饰水平.
- 研究ALKBH5mRNA的稳定性.
- 功能性试验评估ALKBH5在干性和自我更新中的作用.
- 在ALKBH5/SNAI2/YTHDF2轴上的机制研究.
- 评估免疫检查点连接体CD155的表达.
主要成果:
- 通过增加ALKBH5mRNA稳定性,HBV通过降低HCC中的m6A修饰的调节.
- 在HBV阳性HCC中,ALKBH5对维持茎状性至关重要.
- ALKBH5通过去甲基化m6A稳定SNAI2转录,促进癌症干细胞的特征.
- ALKBH5 / SNAI2轴通过激活CD155.5来增强瘤免疫逃避.
结论:
- ALKBH5通过诱导SNAI2.2的m6A脱甲基化,起到与HBV相关的HCC的关键调节者的作用.
- ALKBH5/SNAI2/YTHDF2轴在HBV感染期间促进干细胞类表型和免疫逃生.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


